BCI
ANAB icon

Brinker Capital Investments’s AnaptysBio ANAB Stock Holding History

Brinker Capital Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Sell
11,876
-1,253
-10% -$76K 0.01% 1272
2026
Q1 		$728K Sell
13,129
-1,568
-11% -$84.4K 0.01% 1298
2025
Q4 		$713K Buy
14,697
+958
+7% +$37.3K 0.01% 1426
2025
Q3 		$421K Buy
+13,739
New +$315K ﹤0.01% 1613

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Brinker Capital Investments's ANAB Position: Q2 2026 in Review

Brinker Capital Investments reduced its AnaptysBio (ANAB) stake by 9.5% in Q2 2026, selling an estimated $76K and leaving 11,876 shares worth $802K. The position accounts for 0.01% of the portfolio, ranked #1272.

Brinker Capital Investments first reported a position in ANAB in Q3 2025 and has held it in 4 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Brinker Capital Investments held 11,876 shares of AnaptysBio worth $802K as of Q2 2026.
  • Brinker Capital Investments sold 1,253 AnaptysBio shares in Q2 2026, an estimated $76K.
  • AnaptysBio made up 0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1272 holding.
  • Brinker Capital Investments first reported a position in AnaptysBio in Q3 2025 and has held it in 4 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.